Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12128393 | 0.78 | HTT (0.47) | HTTSMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL959784 | 0.77 | MEN1 (0.37) | HTTSMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL25360339 | 0.77 | MEN1 (0.37) | HTTSMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL2158360 | 0.74 | HTT (0.34) | HTTSMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL16125119 | 0.74 | SORD (0.37) | HTTSMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL14901206 | 0.74 | HTT (0.34) | HTTSMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL3024635 | 0.74 | SMN1; SMN2 (0.35) | HTTSMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL877521 | 0.73 | CRBN (0.35) | HTTMEN1KMT2ANPSR1 | |
| SCHEMBL16125118 | 0.73 | HTT (0.33) | HTTSMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL4650978 | 0.72 | SMN1; SMN2 (0.39) | HTTSMN1; SMN2MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025217330-A1 | CYSTEINE COVALENT MODIFIERS OF AKT1 AND USES THEREOF | TERREMOTO BIOSCIENCES, INC. (US) | 2025-10-16 | — | — | WO | disclosed |
| US-9445593-B1 | Arthropodicidal anthranilamides | E I DU PONT DE NEMOURS AND COMPANY (US) | 2016-09-20 | — | — | US | disclosed |
| US-20160255835-A1 | ARTHROPODICIDAL ANTHRANILAMIDES | FMC CORPORATION | 2016-09-08 | — | — | US | disclosed |
| US-9173400-B2 | Anthranilamide arthropodicide treatment | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-11-03 | — | — | US | disclosed |
| US-9161540-B2 | Cyano anthranilamide insecticides | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-10-20 | — | — | US | disclosed |
| US-9113630-B2 | Method of controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-08-25 | — | — | US | disclosed |
| US-9085578-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-07-21 | — | — | US | disclosed |
| US-9084422-B2 | Anthranilamides compositions | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-07-21 | — | — | US | disclosed |
| US-9078437-B2 | Arthropodicidal anthranilamides | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-07-14 | — | — | US | disclosed |
| US-9049861-B2 | Arthropodicidal anthranilamides | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-06-09 | — | — | US | disclosed |
| WO-2004067528-A1 | CYANO ANTHRANILAMIDE INSECTICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-08-12 | — | — | WO | disclosed |
| EP-1427285-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E. I. du Pont de Nemours and Company (US) | 2004-06-16 | — | — | EP | disclosed |
| EP-1416796-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-05-12 | — | — | EP | disclosed |
| EP-1416797-A1 | ARTHROPODICIDAL ANTHRANILAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-05-12 | — | — | EP | disclosed |
| WO-2004011447-A2 | METHOD FOR PREPARING FUSED OXAZINONES FROM ORTHO-AMINO AROMATIC CARBOXYLIC ACID AND A CARBOXYLIC ACID IN THE PRESENCE OF A SULFONYL CHLORIDE AND PYRIDINE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-02-05 | — | — | WO | disclosed |
| WO-2003106427-A2 | PYRAZOLECARBOXAMIDE INSECTICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-12-24 | — | — | WO | disclosed |
| WO-2003062226-A1 | QUINAZOLINE(DI) ONES FOR INVERTEBRATE PEST CONTROL | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-07-31 | — | — | WO | disclosed |
| WO-2003024222-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-03-27 | — | — | WO | disclosed |
| WO-2003015518-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-02-27 | — | — | WO | disclosed |
| WO-2003015519-A1 | ARTHROPODICIDAL ANTHRANILAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160255835-A1 | ARTHROPODICIDAL ANTHRANILAMIDES | ANTXR2, NIT2, NAAA | HTT 3422/4885SMN1; SMN2 2247/4885MEN1 2273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.